Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SOLIFENACIN Cause Prostatic specific antigen increased? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Prostatic specific antigen increased have been filed in association with SOLIFENACIN (solifenacin succinate). This represents 0.1% of all adverse event reports for SOLIFENACIN.

12
Reports of Prostatic specific antigen increased with SOLIFENACIN
0.1%
of all SOLIFENACIN reports
2
Deaths
1
Hospitalizations

How Dangerous Is Prostatic specific antigen increased From SOLIFENACIN?

Of the 12 reports, 2 (16.7%) resulted in death, 1 (8.3%) required hospitalization.

Is Prostatic specific antigen increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SOLIFENACIN. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does SOLIFENACIN Cause?

Drug ineffective (1,654) Dry mouth (854) Constipation (651) Off label use (522) Dizziness (300) Vision blurred (290) Fall (269) Urinary retention (262) Fatigue (247) Urinary incontinence (246)

What Other Drugs Cause Prostatic specific antigen increased?

ENZALUTAMIDE (3,731) LEUPROLIDE (2,432) ABIRATERONE (1,581) RADIUM RA-223 DICHLORIDE (449) RELUGOLIX (335) BICALUTAMIDE (322) DOCETAXEL (282) APALUTAMIDE (251) DENOSUMAB (220) LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (212)

Which SOLIFENACIN Alternatives Have Lower Prostatic specific antigen increased Risk?

SOLIFENACIN vs SOLIRIS SOLIFENACIN vs SOLOSTAR SOLIFENACIN vs SOLRIAMFETOL SOLIFENACIN vs SOLU-MEDROL SOLIFENACIN vs SOMATREM

Related Pages

SOLIFENACIN Full Profile All Prostatic specific antigen increased Reports All Drugs Causing Prostatic specific antigen increased SOLIFENACIN Demographics